The EHE Foundation

The EHE Foundation, founded in 2015, is a nonprofit 501c3 organization dedicated to pursuing effective treatment for Epithelioid Hemangioendothelioma (EHE), an ultra-rare and potentially aggressive cancer that affects one in a million people. The Foundation supports patients, advances research, and fosters collaboration among clinicians and researchers worldwide. A core component of The EHE Foundation's mission is to fund innovative and impactful research leading to effective treatments and a cure for EHE. EHE is a rare vascular sarcoma cancer that affects all age groups from children to elderly. Little is known about this cancer, which, in its aggressive form, is highly destructive and normally fatal. Our mission is to find treatments and a cure for this rare cancer by advancing research and driving collaboration between patients, researchers, and clinicians. We envision a world where Epithelioid Hemangioendothelioma (EHE) is easily diagnosed and treatable. The EHE Biobank is an open, ongoing collection of tissue samples and other biospecimens, including blood and bodily fluids donated by people with EHE. The Biobank has been developed by The EHE Foundation with the generous support of private donations and grants to accelerate EHE research.